WATCH OUT FOR IMPACT OF RESULTS ON STOCK

Watch out for the impact of results on the below mentioned stock :- Sanofi India Ltd. (SIL) posted steady growth in the fourth quarter of 2024, with revenue increasing by 9.7% year-on-year (YoY) to ₹514.9 crore, compared to ₹469.2 crore in the corresponding quarter of the previous year. EBITDA rose 18.8% YoY to ₹118.3 crore, up from ₹99.6 crore. Operating margins also improved to 23%, compared to 21.2% in Q4 2023. However, the company’s net profit declined by 33.7% to ₹91.3 crore, down from ₹137.7 crore a year ago.